* Avanos Medical Inc AVNS.N AVNS.K is expected to show a
rise
in quarterly revenue when it reports results on May 4.
* The Alpharetta Georgia-based company is expected to
report a
9.5% increase in revenue to $197.8 million from $180.7 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Avanos Medical Inc
is for
earnings of 26 cents per share. For the same quarter last year,
the company reported earnings of 23 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Avanos
Medical
Inc is $39, above its last closing price of $29.16.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 0.40 0.40 0.46 Beat 14.4
Sep. 30 2021 0.29 0.30 0.25 Missed -17.1
Jun. 30 2021 0.23 0.23 0.21 Missed -10
Mar. 31 2021 0.18 0.19 0.23 Beat 24.3
Dec. 0.22 0.22 0.28 Beat 29.2
31 2020
Sep. 30 2020 0.11 0.10 0.21 Beat 110
Jun. 30 2020 -0.08 -0.10 0.13 Beat 230
Mar. 31 2020 0.15 0.16 0.16 Met 1.6
This summary was machine generated May 2 at 18:34 GMT. All
figures in US dollars unless otherwise stated